Cirugía de vitrectomía para el tratamiento de las complicaciones vítreo-retinianas asociadas a pars planitis

Molina-Prat, Nicolás; Adán, Alfredo; Mesquida, Marina; Pelegrini, L.; Rey, Amanda; Álvarez, G.

doi:10.1016/j.oftal.2010.07.003

Cited by 13 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many authors have reported that vitrectomy resolved these complications, improved visual acuity, and alleviated intraocular inflammation in a variety of uveitis groups including IU [5–9, 15, 19–22]. Molina-Prat et al [9] reported that visual acuity improvement was observed in 20 of 22 eyes (90.9%) and that the clinical course was improved in 19 eyes (86.4%), allowing for suspension of systemic treatment in 16 pars planitis patients.…”

Section: Discussionmentioning

confidence: 99%

“…Molina-Prat et al [9] reported that visual acuity improvement was observed in 20 of 22 eyes (90.9%) and that the clinical course was improved in 19 eyes (86.4%), allowing for suspension of systemic treatment in 16 pars planitis patients. Our present results reconfirmed that vitrectomy was a useful treatment modality for IU: 44 of 66 patients (66.7%) suffered no uveitis attacks after vitrectomy and 46 of 66 patients (69.7%) showed BCVA improvement.…”

Section: Discussionmentioning

confidence: 99%

“…Several authors have reported that vitrectomy effectively alleviated intraocular inflammation and improved visual acuity in IU [5–9]. To achieve optimal outcomes, it was recommended that a clinically quiescent state with no intraocular inflammation should be maintained for at least three months before surgery [10–14].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis

Shin

Joong

et al. 2017

Journal of Ophthalmology

View full text Add to dashboard Cite

Purpose. To demonstrate the long-term effectiveness of vitrectomy for intermediate uveitis (IU) and to determine whether complete control of inflammation before vitrectomy is necessary. Methods. This retrospective study included 66 eyes of 66 patients with IU who underwent vitrectomy for vitreoretinal complications. Eyes were followed for at least 12 months after vitrectomy. The degree of inflammation control and visual acuity were compared before and after vitrectomy. These parameters were compared according to the presence of complete inflammation control before surgery. Results. The indications of vitrectomy included epiretinal membrane (26 eyes), vitreous opacity (21 eyes), and tractional retinal detachment (12 eyes), among others. Uveitic attacks did not occur in 44 of the 66 patients after vitrectomy. The numbers of uveitis attacks, local steroid injections, and systemic medications significantly decreased, and vision meaningfully improved after vitrectomy. These parameters did not differ significantly, regardless of the presence of preoperative inflammation. Conclusions. This study showed that vitrectomy is a good modality to manage vitreoretinal complications associated with IU, even if complete control of intraocular inflammation is not achieved before vitrectomy.

show abstract